IGC Pharma, a company based in Maryland, requires regulatory approval from the FDA and files reports with the SEC.
1 report, 0 independent
Updated Jun 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
IGC Pharma, a company based in Maryland, requires regulatory approval from the FDA and files reports with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.
- Unicycive Therapeutics, Inc. is facing investigator findings regarding manufacturing compliance issues from the FDA.
- EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.
- A company is seeking FDA 510(k) clearance while simultaneously conducting a private placement and qualifying its prospectus in British Columbia.
Coverage
Newest first; wire copies grouped- Unknown outlet